Thursday , April 26 2018
Home / Resources (page 1302)



Issue 132 Item 3 ASPART VS. LISPRO and the Winner IS!

A group of researchers led by Dr Johannes Plank from the Karl-Franzens University of Graz in Austria, compared the pharmacokinetic and pharmacodynamic profiles of insulin aspart and insulin lispro and their effects on postprandial blood glucose excursions in patients with type 1 diabetes.

Read More »